RGRolf David Glaser

Rolf David Glaser

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rolf David Glaser has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Learta Pervizaj-Oruqaj

    Cardiopulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Institute for Lung Health (ILH), Member of the German Center for Lung Research (DZL), Justus-Liebig University of Giessen, Germany

    3 shared publications
  • Werner Seeger

    Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC) Member of the German Center for Lung Research (DZL) Giessen Germany

    3 shared publications
  • Balachandar Selvakumar

    Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates

    2 shared publications
  • Christina Malainou

    Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus Liebig University Giessen

    2 shared publications
  • István Vadász

    Department of Internal Medicine, Justus Liebig University, Universities of Giessen and Marburg Lung Center, Giessen, Germany

    2 shared publications
  • Jochen Wilhelm

    Institute for Lung Health (ILH), Universities Giessen & Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig-University Giessen, Giessen, Germany

    2 shared publications

Latest Publications

  • Open Access

    Mitochondrial COX4I2 drives pericyte-dependent inflammation and emphysema

    by Claudia F. Garcia Castro, Vidya Srokshna Balasubramanian Lakshmi, Stefan Hadzic, Claudio Nardiello, Rolf D. Glaser, Maik Hüttemann, Lawrence I. Grossman, Baktybek Kojonazarov, Muchen Li, Sandipan Jash, et al.

    Chronic obstructive pulmonary disease (COPD) is characterized by neutrophilic inflammation, emphysema, and mild pulmonary hypertension (PH). Oxidative/nitrosative stress are key drivers, but specific mitochondrial mechanisms remain unclear. We show increased expression of the regulatory mitochondrial cytochrome c oxidase subunit 4 isoform 2 (COX4I2) in an early murine model and human COPD. After 8 months of cigarette smoke exposure, Cox4i2 −/− mice were completely protected from emphysema but not from PH, associated with reduced nitrosative stress, inflammation, and apoptosis. Using a novel Cox4i2 reporter mouse and in situ hybridization of human lungs, COX4I2 was detected in precapillary ACTA2 + cells and capillary pericytes. COX4I2 promotes mitochondrial reactive oxygen species (mtROS) production in these cells, thereby enhancing neutrophil migration and alveolar type II cell apoptosis, and modulates angiogenesis. In contrast to Cox4i2 −/− , mitochondria-targeted antioxidant MitoQ reversed emphysema and PH, suggesting pericyte-specific regulation of COPD pathologies and mtROS inhibition as a therapeutic approach in COPD. Graphical

  • Top Cited Papers
    Open Access

    Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia

    by Learta Pervizaj-Oruqaj, Balachandar Selvakumar, Maximiliano Ruben Ferrero, Monika Heiner, Christina Malainou, Rolf David Glaser, Jochen Wilhelm, Marek Bartkuhn, Astrid Weiss, Ioannis Alexopoulos, et al.

    Influenza A virus (IAV) infection mobilizes bone marrow-derived macrophages (BMDM) that gradually undergo transition to tissue-resident alveolar macrophages (TR-AM) in the inflamed lung. Combining high-dimensional single-cell transcriptomics with complex lung organoid modeling, in vivo adoptive cell transfer, and BMDM-specific gene targeting, we found that transitioning (“regenerative”) BMDM and TR-AM highly express Placenta-expressed transcript 1 (Plet1). We reveal that Plet1 is released from alveolar macrophages, and acts as important mediator of macrophage-epithelial cross-talk during lung repair by inducing proliferation of alveolar epithelial cells and re-sealing of the epithelial barrier. Intratracheal administration of recombinant Plet1 early in the disease course attenuated viral lung injury and rescued mice from otherwise fatal disease, highlighting its therapeutic potential.